MedTrace Logo

Remote Trial - Tobacco Product Standard (VLNC)

NCT06442384 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-04-10

No results posted yet for this study

Summary

The goal of this pilot project is to explore the feasibility of a real-world marketplace study design examining the effects of a reduced nicotine product standard for cigarettes on smoking in the context of a flavor restriction vs. no restriction on e-cigarettes in smokers switched to very low nicotine content cigarettes.

Conditions

  • Tobacco Use

Interventions

OTHER

Tobacco and non-tobacco e-cigarettes

Participants with no e-cigarette restrictions.

OTHER

Tobacco only e-cigarettes

Participants restricted to tobacco flavored e-cigarettes only.

Sponsors & Collaborators

  • Masonic Cancer Center, University of Minnesota

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-11
Primary Completion
2025-04-07
Completion
2025-04-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06442384 on ClinicalTrials.gov